Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Elusys Therapeutics
Develops antibody-based therapies to treat infectious diseases.
Pine Brook, NJ
Contact:
Ron Eastman
Formerly Known As: E-Site Therapeutics
Related News
Elusys Therapeutics’ Anthrax Drug Gains FDA Approval in Adults and Children
Elusys Therapeutics Receives First Delivery Order from US Government for Anthim
Elusys Awarded Additional $16 Million To Complete Development of Lyophilized Form of Anthim
Elusys Therapeutics Presents Efficacy Results and Other Key Findings on ETI-204 Anthrax Anti-Toxin